Abstract
The role of 1,25-dihydroxyvitamin D 3 (1,25-(OH)2 D 3 ) as a regulator of cell growth and differentiation is well recognized. Currently, 1,25-(OH)2 D 3 and vitamin D analogs are being evaluated for their therapeutic potential in the treatment of hyperproliferative disorders like cancer. In the present review, we will discuss several processes that might be involved in 1,25-(OH)2 D 3 - and vitamin D analog-mediated suppression of cancer cell growth. The effects on tumor cell proliferation, differentiation, apoptosis, angiogenesis, metastases, and parathyroid hormone-related peptide secretion will be highlighted. In addition, combination therapy with other tumor effective drugs will be addressed. Furtermore, we will focus on the potential drawbacks and the possible side effects of vitamin D compounds in the treatment of cancer.
Keywords: Anti Tumor, 1 25 Dihydroxyvitamin D3, Vitamin D Analogs, Cancer, Breast Carcinoma, Myeloid leukemia, Cervical Carcinoma, Osteosarcoma, Colon carcinoma, Ovarian carcinoma, Colorectal carcinoma/kwd, >, Pancreatic carcinoma, Fibrosarcoma, Pituitary Adenoma, Gall Bladder carcinoma, Prostate carcinoma, Intestine carcinoma, Renal cell carcinoma, Lung carcinoma, Squamous cell carcinoma, Lymphocytic leukemia, Transitional bladder carcinoma, Melanoma, Thyroid carcinoma, Medullary thyroid carcinoma, Uterine carcinosarcoma, Reduced angiogenesis, Tumor suppression, Reduction of metastases, Cell proliferation, Apoptosis, Cell differentiation, Angiogenesis, Parathyroid hormone related peptide PTH rP, Metasaes, Growth factor, Osteosarcoma human, Prostate human, Melanoma human, erythroleukemia cell line K 562, Parathyroid Hormone Related Peptide Secretion, Metastasis, cadherins fibronectin VCAM 1, Vitamin D Resistance, 22 Oxo 1 25 dihydroxyvitamin D3, Transforming growth factor
Current Pharmaceutical Design
Title: Anti-Tumor Effects of 1,25-Dihydroxyvitamin D3 and Vitamin D Analogs
Volume: 6 Issue: 7
Author(s): Gert-Jan C.M. van den Bemd, Huibert A.P. Pols and Johannes P.T.M. van Leeuwen
Affiliation:
Keywords: Anti Tumor, 1 25 Dihydroxyvitamin D3, Vitamin D Analogs, Cancer, Breast Carcinoma, Myeloid leukemia, Cervical Carcinoma, Osteosarcoma, Colon carcinoma, Ovarian carcinoma, Colorectal carcinoma/kwd, >, Pancreatic carcinoma, Fibrosarcoma, Pituitary Adenoma, Gall Bladder carcinoma, Prostate carcinoma, Intestine carcinoma, Renal cell carcinoma, Lung carcinoma, Squamous cell carcinoma, Lymphocytic leukemia, Transitional bladder carcinoma, Melanoma, Thyroid carcinoma, Medullary thyroid carcinoma, Uterine carcinosarcoma, Reduced angiogenesis, Tumor suppression, Reduction of metastases, Cell proliferation, Apoptosis, Cell differentiation, Angiogenesis, Parathyroid hormone related peptide PTH rP, Metasaes, Growth factor, Osteosarcoma human, Prostate human, Melanoma human, erythroleukemia cell line K 562, Parathyroid Hormone Related Peptide Secretion, Metastasis, cadherins fibronectin VCAM 1, Vitamin D Resistance, 22 Oxo 1 25 dihydroxyvitamin D3, Transforming growth factor
Abstract: The role of 1,25-dihydroxyvitamin D 3 (1,25-(OH)2 D 3 ) as a regulator of cell growth and differentiation is well recognized. Currently, 1,25-(OH)2 D 3 and vitamin D analogs are being evaluated for their therapeutic potential in the treatment of hyperproliferative disorders like cancer. In the present review, we will discuss several processes that might be involved in 1,25-(OH)2 D 3 - and vitamin D analog-mediated suppression of cancer cell growth. The effects on tumor cell proliferation, differentiation, apoptosis, angiogenesis, metastases, and parathyroid hormone-related peptide secretion will be highlighted. In addition, combination therapy with other tumor effective drugs will be addressed. Furtermore, we will focus on the potential drawbacks and the possible side effects of vitamin D compounds in the treatment of cancer.
Export Options
About this article
Cite this article as:
van den Bemd C.M. Gert-Jan, Pols A.P. Huibert and van Leeuwen P.T.M. Johannes, Anti-Tumor Effects of 1,25-Dihydroxyvitamin D3 and Vitamin D Analogs, Current Pharmaceutical Design 2000; 6 (7) . https://dx.doi.org/10.2174/1381612003400498
DOI https://dx.doi.org/10.2174/1381612003400498 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Application of Selenium Nanoparticles in Localized Drug Targeting for Cancer
Therapy
Anti-Cancer Agents in Medicinal Chemistry Vitamin D Represses the Aggressive Potential of Osteosarcoma
Endocrine, Metabolic & Immune Disorders - Drug Targets Interactions Between Proteins and Platinum-Containing Anti-Cancer Drugs
Mini-Reviews in Medicinal Chemistry Signal Transducer and Activator of Transcription 3 Signaling Pathway: A Potential Target in Sarcoma Treatment
Current Enzyme Inhibition p53 Peptide Prevents LITAF-Induced TNF-Alpha-Mediated Mouse Lung Lesions and Endotoxic Shock
Current Molecular Medicine Diverse Roles of GADD45α in Stress Signaling
Current Protein & Peptide Science RNAi in Clinical Studies
Current Medicinal Chemistry Inhibition of TGF- Signaling for the Treatment of Tumor Metastasis and Fibrotic Diseases
Current Signal Transduction Therapy Antigenic Peptide Vaccination: Provoking Immune Response and Clinical Benefit for Cancer
Current Immunology Reviews (Discontinued) Cytotoxicity and Target Modulation in Pediatric Solid Tumors by the Proteasome Inhibitor Carfilzomib
Current Cancer Drug Targets Conventional Anticancer Therapeutics and Telomere Maintenance Mechanisms
Current Pharmaceutical Design Therapeutic Potential and Outlook of Alternative Medicine for Osteoporosis
Current Drug Targets Novel Mediators of Vitamin D Signaling in Cancer and Obesity
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) A Fresh Prospect of Extracellular Matrix Hydrolytic Enzymes and Their Substrates
Current Pharmaceutical Design Update on Statins: Hope for Osteoporotic Fracture Healing Treatment
Current Drug Targets Targeting Cancer Stem Cells Pathways for the Effective Treatment of Cancer
Current Drug Targets Drug Therapy of Neuropathic Pain: Current Developments and Future Perspectives
Current Drug Targets Harnessing the Potential of Long Non-coding RNAs to Manage Metabolic Diseases
Current Pharmaceutical Design Molecular Mechanisms Regulating Matrix Metalloproteinases
Current Topics in Medicinal Chemistry Bispecific Antibodies: An Innovative Arsenal to Hunt, Grab and Destroy Cancer Cells
Current Pharmaceutical Biotechnology